Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Labetalol and other agents that block both alpha- and beta-adrenergic receptors
    Donald G. Vidt, MD, Alan Bakst, PharmD, Carolyn J. Pearce, MD and J. David Wallin, MD
    Cleveland Clinic Journal of Medicine January 1994, 61 (1) 59-69;

    A review of how these agents can be used in managing difficult-to-control hypertension.

  • You have access
    Durability of bipolar coaxial endocardial pacemaker leads compared with unipolar leads
    Marcelo E. Helguera, MD, Sergio L. Pinski, MD, James D. Maloney, MD, Javier R. Woscoboinik, MD, Richard G. Trohman, MD, Victor A. Morant, MD, Bruce L. Wilkoff, MD and Lon W. Castle, MD
    Cleveland Clinic Journal of Medicine January 1994, 61 (1) 25-28;

    Bipolar coaxial leads are preferable to unipolar leads in most aspects. Yet survival of bipolar coaxial leads in long-term follow-up studies seems worse than that of unipolar leads, indicating the need to reevaluate the risk-benefit ratio of the coaxial design.

  • You have access
    Ovarian cancer update: management challenges and advances
    Maurie Markman, MD
    Cleveland Clinic Journal of Medicine January 1994, 61 (1) 51-58;

    Suspicion of ovarian cancer is especially important when working up postmenopausal women with vague abdominal complaints or a palpable ovary.

  • You have access
    Diagnostic evaluation of the patient with coronary artery disease
    Fredric J. Pashkow, MD
    Cleveland Clinic Journal of Medicine January 1994, 61 (1) 43-48;

    Evaluation of patients with possible CAD involves balancing conflicting considerations, such as test sensitivity and accuracy, cost, and access.

  • You have access
    Enteropathic arthritis
    Verna Wright, MD
    Cleveland Clinic Journal of Medicine January 1994, 61 (1) 14-16;

    A brief overview of intestinal diseases associated with arthropathy, including ulcerative colitis, Crohn’s disease, dysentery, and Whipple’s disease.

  • You have access
    Intrahepatic cholestasis during nicotinic acid therapy
    Sanat D. Patel, MD and Harris C. Taylor, MD
    Cleveland Clinic Journal of Medicine January 1994, 61 (1) 70-75;
  • You have access
    Management of kidney stones: how new technology has affected the indications for intervention
    Stevan B. Streem, MD
    Cleveland Clinic Journal of Medicine January 1994, 61 (1) 13-14;

    Now that stones can be treated noninvasively on an outpatient basis, intervention is often less expensive and more humane than to "wait and see."

  • You have access
    Issues in the diagnosis and management of malignant disease
    Maurie Markman, MD
    Cleveland Clinic Journal of Medicine January 1994, 61 (1) 50;

    Introduction to a new regular series of succinct reviews of cancer care relevant to non-oncologists.

  • You have access
    In reply: DNR orders and length of stay
    George A. Kanoti, STD
    Cleveland Clinic Journal of Medicine January 1994, 61 (1) 79;
  • You have access
    Glycemic control and complications of diabetes mellitus: practical implications of the Diabetes Control and Complications Trial (DCCT)
    Byron J. Hoogwerf, MD and Ben H. Brouhard, MD
    Cleveland Clinic Journal of Medicine January 1994, 61 (1) 34-37;

    The DCCT results provide new impetus to find better ways to achieve near-normal glycemia.

Pages

  • Previous
  • Next
  • 1
  • …
  • 477
  • 478
  • 479
  • 480
  • 481
  • 482
  • 483
  • 484
  • 485
  • …
  • 798

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire